Clinical Trial Update: Letrozole in Patients With Ovarian Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial of letrozole in patients with ovarian tumors (ovarian, fallopian tube, and peritoneal cancer) was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: TERMINATED | Results posted: 2010-10-19